Navigation Links
Prospero Group (PRPG) and Fincor (FINC) Made a Share Transfer and Enter the Market with ACTRx a New Malaria and Dengue Fever Treatment

NEW YORK and NASSAU, The Bahamas, April 30 /PRNewswire-FirstCall/ -- Prospero Group (PRPG) invested into the Private Placement Plan of Fincor (FINC) through a 1:1 share split. Prospero Group a leading company in the field of Water Technologies enlarges thru Fincor its portfolio with the new ACTRx Malaria and Dengue fever treatment. Fincor also acquired the WETTECH and Advanced Cavitation Technologies.

Prospero Group enlarges its technology portfolio with ACTRx, which combines several natural drugs to fight Malaria and Dengue fever. Prospero Group's largest shareholder, Fincor acquired a majority on ACTRx International Inc. to become the premier global supplier of Malaria and Dengue cures, preventatives, maintenance and information products and services.

Both Malaria and Dengue fever appear in the human landscape and seem to have only nebulous solutions that work sporadically in over one half of the countries in the world. Yet there are countries that have enjoyed the disappearance of both of these mosquito born diseases. Prospero Group's intention is to research, review and objectively resolve the issues that keep these diseases active in our global society.

Fincor also acquired WETTECH marketed as Prospero Water Technologies and the Advanced Cavitation Technology.

Prospero Group intends to make further strategic acquisitions of proven, reliable and innovative technologies to its portfolio.

It was decided by the Board Members of Prospero Group on Friday, April 24, 2009 to invest into the Private Placement Plan of Fincor Inc. through a 1:1 share split of Prospero Group shareholdings.

About Prospero Group: Prospero Group is a U.S. and Bahamian technology development company whose primary focus is developing and producing technologies for potable water and alternative energy systems. Our market developments are concentrated in The Bahamas, United States of America, Latin America, Europe and Far East. One of the actual projects is to enable customers to sell "Green" water and energy products. The basis of the Prospero Water Technologies campaign will be its Advanced Cavitation Technology (ACT), "WETTECH", Planets Purest Water and other Air Water generating machines.

About Fincor Inc.: Fincor Inc. is a technology and pharmaceutical company. It has recently acquired ACTRx International Inc. which produces Malaria and Dengue fever drugs in order to become the premier global supplier of Malaria and Dengue cures, preventatives, maintenance and information products and services. Fincor Inc. also acquired Advanced Cavitation Technology ("WETTECH"), which produces 1000 gallons (200 liters) per hour of high purity distilled water. Using this technology, consistently delivers the highest purity product water at the lowest overall cost with a minimum of maintenance.

Allowing the liquid to become the heat source, rather than a hot surface as in conventional applications eliminates the problems of scale build-up and fouling associated with the heating of impure liquids. So the device provides efficient, simple, inexpensive and reliable sources of distilled potable water for residential, commercial and industrial use. The Cavitation Technology operates at a very low operating cost and is the only water purification of its type to be fully clean-in-place (CIP) capable at such large capacity of delivering potable water.

SOURCE Prospero Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International Coal Group Is Lead Sponsor for West Virginia Susan G. Komen Race For The Cure
2. Pandemic Flu Preparedness Guides for Families, Businesses, Medical Providers, and Community Groups Released by Trust for Americas Health
3. Top Policy Groups Take Action to Create Healthy Communities, Prevent Childhood Obesity
4. Unsung Heroes of Health Care Reform?: $36 Billion in Annual Savings Linked to Group Purchasing Organizations in Major Survey of Over 400 Hospitals
5. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
6. Salmon of the Americas Responds to PEW Environmental Group
7. Less Than a Year After CDC Announced the U.S. HIV Epidemic Is Much Larger Than Previously Thought, Publics Sense of Urgency Is Down, Even Among Some Higher Risk Groups
8. Guidelines for medical home demonstrations released by major physician groups
9. The Quantum Group Announces Filing of Utility Patent Application
10. Product Shifts are Occurring in the Renal Anemia and Bone and Mineral Metabolism Markets According to the Most Recent TreatmentTrends(R): US Nephrology Report from BioTrends Research Group
11. New Report by BioTrends Research Group to Highlight the Launch of SIMPONI(R) (golimumab)
Post Your Comments:
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: